Divi's Laboratories Limited (DIVISLAB) Share Analysis
NSE · Healthcare · Pharmaceuticals
Divi's Laboratories Limited (NSE: DIVISLAB) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 500. As of 14 Nov 2026, the share price was ₹11,442.00, P/E 88.9, ROE 16.5%.
Get the AI verdict on DIVISLAB: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
DIVISLAB chart with trendlines
Is DIVISLAB a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Divi's Laboratories Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
DIVISLAB key facts
| Price and valuation | |
|---|---|
| Share price | ₹11,442.00 |
| Market cap | ₹3.04L Cr |
| P/E ratio | 88.9 |
| P/B ratio | 16.88 |
| EPS | ₹126.68 |
| Book value per share | ₹678.00 |
| Dividend yield | 0.26% |
| 52-week range | |
| 52-week high | ₹11,824.00 |
| 52-week low | ₹5,647.50 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 51.87% |
| FIIs | 20.38% |
| DIIs | 19.08% |
| Public | 8.58% |
Index membership: NIFTY 100, NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Next 50, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.